Improving HIV prevention strategies in Zimbabwe and Kwazulu Natal
From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal
This study is looking for better ways to prevent HIV by focusing on people who are at higher risk, especially those dealing with alcohol use and mental health challenges, and it will test helpful tools like text reminders to keep them engaged in their care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10662318 on NIH RePORTER |
What this research studies
This research aims to enhance HIV prevention efforts by optimizing resource allocation and targeting specific interventions for high-risk populations, particularly those with alcohol use disorders and mental health issues. It utilizes mathematical modeling and surveillance data to identify effective strategies that can be implemented in resource-limited settings. The study will assess various tools, including SMS reminders for appointments and medications, to improve engagement in HIV care. By tailoring these strategies, the research seeks to meet the UNAIDS 2030 goals for reducing HIV incidence.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in Zimbabwe and Kwazulu Natal who are at high risk for HIV, particularly those with alcohol use disorders or mental health conditions.
Not a fit: Patients who do not reside in the targeted regions or who do not have risk factors associated with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV prevention and care strategies, ultimately reducing the incidence of HIV in targeted populations.
How similar studies have performed: Previous research has shown success in using targeted interventions and mathematical modeling to improve health outcomes in similar contexts, indicating that this approach has potential.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Braithwaite, Ronald Scott — New York University School of Medicine
- Study coordinator: Braithwaite, Ronald Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.